ID   PYL2_ARATH              Reviewed;         190 AA.
AC   O80992;
DT   02-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-JUL-2015, entry version 86.
DE   RecName: Full=Abscisic acid receptor PYL2;
DE   AltName: Full=PYR1-like protein 2;
DE   AltName: Full=Regulatory components of ABA receptor 14;
GN   Name=PYL2; Synonyms=RCAR14; OrderedLocusNames=At2g26040;
GN   ORFNames=T19L18.15;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Resource (TAIR);
RL   Submitted (APR-2011) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY.
RX   PubMed=19407143; DOI=10.1126/science.1172408;
RA   Ma Y., Szostkiewicz I., Korte A., Moes D., Yang Y., Christmann A.,
RA   Grill E.;
RT   "Regulators of PP2C phosphatase activity function as abscisic acid
RT   sensors.";
RL   Science 324:1064-1068(2009).
RN   [4]
RP   INTERACTION WITH HAB1, GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19407142; DOI=10.1126/science.1173041;
RA   Park S.-Y., Fung P., Nishimura N., Jensen D.R., Fujii H., Zhao Y.,
RA   Lumba S., Santiago J., Rodrigues A., Chow T.F., Alfred S.E.,
RA   Bonetta D., Finkelstein R., Provart N.J., Desveaux D., Rodriguez P.L.,
RA   McCourt P., Zhu J.-K., Schroeder J.I., Volkman B.F., Cutler S.R.;
RT   "Abscisic acid inhibits type 2C protein phosphatases via the PYR/PYL
RT   family of START proteins.";
RL   Science 324:1068-1071(2009).
RN   [5]
RP   FUNCTION, MUTAGENESIS OF VAL-87 AND ILE-88, HOMODIMER, AND GENE
RP   FAMILY.
RX   PubMed=21658606; DOI=10.1016/j.molcel.2011.05.011;
RA   Hao Q., Yin P., Li W., Wang L., Yan C., Lin Z., Wu J.Z., Wang J.,
RA   Yan S.F., Yan N.;
RT   "The molecular basis of ABA-independent inhibition of PP2Cs by a
RT   subclass of PYL proteins.";
RL   Mol. Cell 42:662-672(2011).
RN   [6]
RP   FUNCTION, AND GENE FAMILY.
RX   PubMed=23844015; DOI=10.1371/journal.pone.0067477;
RA   Zhang X., Jiang L., Wang G., Yu L., Zhang Q., Xin Q., Wu W., Gong Z.,
RA   Chen Z.;
RT   "Structural insights into the abscisic acid stereospecificity by the
RT   ABA receptors PYR/PYL/RCAR.";
RL   PLoS ONE 8:E67477-E67477(2013).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 14-188 IN COMPLEX WITH
RP   ABSCISIC ACID AND PP2C HAB1, DIMERIZATION, FUNCTION, INTERACTION WITH
RP   HAB1; ABI1 AND ABI2, GATE AND LATCH MOTIFS, MUTAGENESIS OF LYS-64;
RP   VAL-87; GLY-90; LEU-91; ALA-93; GLU-98; TYR-124; GLU-147; VAL-151 AND
RP   ASN-173, AND DOMAIN.
RX   PubMed=19898420; DOI=10.1038/nature08613;
RA   Melcher K., Ng L.-M., Zhou X.E., Soon F.-F., Xu Y., Suino-Powell K.M.,
RA   Park S.-Y., Weiner J.J., Fujii H., Chinnusamy V., Kovach A., Li J.,
RA   Wang Y., Li J., Peterson F.C., Jensen D.R., Yong E.-L., Volkman B.F.,
RA   Cutler S.R., Zhu J.-K., Xu H.E.;
RT   "A gate-latch-lock mechanism for hormone signalling by abscisic acid
RT   receptors.";
RL   Nature 462:602-608(2009).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) ALONE AND IN COMPLEX WITH
RP   ABSCISIC ACID, FUNCTION, INTERACTION WITH ABI1, AND MUTAGENESIS OF
RP   LYS-64.
RX   PubMed=19893533; DOI=10.1038/nsmb.1730;
RA   Yin P., Fan H., Hao Q., Yuan X., Wu D., Pang Y., Yan C., Li W.,
RA   Wang J., Yan N.;
RT   "Structural insights into the mechanism of abscisic acid signaling by
RT   PYL proteins.";
RL   Nat. Struct. Mol. Biol. 16:1230-1236(2009).
CC   -!- FUNCTION: Receptor for abscisic acid (ABA) required for ABA-
CC       mediated responses such as stomatal closure and germination
CC       inhibition. Inhibits the activity of group-A protein phosphatases
CC       type 2C (PP2Cs) when activated by ABA (PubMed:19893533,
CC       PubMed:19898420, PubMed:23844015, PubMed:21658606). Can be
CC       activated by both (-)-ABA and (+)-ABA (PubMed:23844015).
CC       {ECO:0000269|PubMed:19893533, ECO:0000269|PubMed:19898420,
CC       ECO:0000269|PubMed:21658606, ECO:0000269|PubMed:23844015}.
CC   -!- SUBUNIT: Homodimer (PubMed:19898420, PubMed:21658606). Binds ABA
CC       on one subunit only. Interacts with HAB1, ABI1 and ABI2, and
CC       possibly with other PP2Cs (PubMed:19407142, PubMed:19893533,
CC       PubMed:19898420). Binds to CARs protein in an ABA-independent
CC       manner, both at the plasma membrane and in the nucleus (By
CC       similarity). {ECO:0000250|UniProtKB:O49686,
CC       ECO:0000269|PubMed:19407142, ECO:0000269|PubMed:19893533,
CC       ECO:0000269|PubMed:19898420, ECO:0000269|PubMed:21658606}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9FLB1}.
CC       Nucleus {ECO:0000250|UniProtKB:O49686}. Cell membrane
CC       {ECO:0000250|UniProtKB:O49686}. Note=Localizes at the plasma
CC       membrane in the presence of a CAR protein.
CC       {ECO:0000250|UniProtKB:O80920}.
CC   -!- DOMAIN: Upon interaction with ABA, the 'latch' and 'gate' loops
CC       change in conformation leading to a tight dimerization and the
CC       creation a surface that enables the receptor to dock into and
CC       inhibit the PP2C active site. {ECO:0000269|PubMed:19898420}.
CC   -!- SIMILARITY: Belongs to the PYR/PYL/RCAR abscisic acid
CC       intracellular receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004747; AAC31232.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07788.1; -; Genomic_DNA.
DR   PIR; T02619; T02619.
DR   RefSeq; NP_180174.1; NM_128163.1.
DR   UniGene; At.66246; -.
DR   PDB; 3KAZ; X-ray; 1.85 A; A/B/C=14-188.
DR   PDB; 3KB0; X-ray; 1.95 A; A=14-188.
DR   PDB; 3KB3; X-ray; 1.95 A; A=14-188.
DR   PDB; 3KDH; X-ray; 1.65 A; A/B/C=1-190.
DR   PDB; 3KDI; X-ray; 2.38 A; A=1-190.
DR   PDB; 3KL1; X-ray; 1.55 A; A/B=1-190.
DR   PDB; 3NJ0; X-ray; 1.89 A; A/B/C=1-190.
DR   PDB; 3NJ1; X-ray; 1.95 A; A=1-190.
DR   PDB; 3NMH; X-ray; 1.85 A; A/B/C=14-189.
DR   PDB; 3NMP; X-ray; 2.10 A; A/B/C=14-189.
DR   PDB; 3NMT; X-ray; 2.56 A; A=14-189.
DR   PDB; 3NMV; X-ray; 2.10 A; A=14-189.
DR   PDB; 3NR4; X-ray; 2.01 A; A/B/C=1-190.
DR   PDB; 3NS2; X-ray; 1.63 A; A/B/C=1-190.
DR   PDB; 3UJL; X-ray; 2.50 A; A=14-188.
DR   PDB; 4LA7; X-ray; 1.98 A; A=1-190.
DR   PDB; 4LG5; X-ray; 2.88 A; A=14-188.
DR   PDB; 4LGA; X-ray; 2.70 A; A=14-188.
DR   PDB; 4LGB; X-ray; 3.15 A; A=14-188.
DR   PDBsum; 3KAZ; -.
DR   PDBsum; 3KB0; -.
DR   PDBsum; 3KB3; -.
DR   PDBsum; 3KDH; -.
DR   PDBsum; 3KDI; -.
DR   PDBsum; 3KL1; -.
DR   PDBsum; 3NJ0; -.
DR   PDBsum; 3NJ1; -.
DR   PDBsum; 3NMH; -.
DR   PDBsum; 3NMP; -.
DR   PDBsum; 3NMT; -.
DR   PDBsum; 3NMV; -.
DR   PDBsum; 3NR4; -.
DR   PDBsum; 3NS2; -.
DR   PDBsum; 3UJL; -.
DR   PDBsum; 4LA7; -.
DR   PDBsum; 4LG5; -.
DR   PDBsum; 4LGA; -.
DR   PDBsum; 4LGB; -.
DR   ProteinModelPortal; O80992; -.
DR   SMR; O80992; 8-188.
DR   BioGrid; 2497; 4.
DR   DIP; DIP-48582N; -.
DR   IntAct; O80992; 2.
DR   STRING; 3702.AT2G26040.1; -.
DR   PaxDb; O80992; -.
DR   PRIDE; O80992; -.
DR   EnsemblPlants; AT2G26040.1; AT2G26040.1; AT2G26040.
DR   GeneID; 817145; -.
DR   KEGG; ath:AT2G26040; -.
DR   TAIR; AT2G26040; -.
DR   eggNOG; NOG299178; -.
DR   HOGENOM; HOG000238422; -.
DR   InParanoid; O80992; -.
DR   KO; K14496; -.
DR   OMA; HFIKSCD; -.
DR   PhylomeDB; O80992; -.
DR   EvolutionaryTrace; O80992; -.
DR   PRO; PR:O80992; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0010427; F:abscisic acid binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IDA:UniProtKB.
DR   GO; GO:0009738; P:abscisic acid-activated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IDA:GOC.
DR   Gene3D; 3.30.530.20; -; 1.
DR   InterPro; IPR019587; Polyketide_cyclase/dehydratase.
DR   InterPro; IPR023393; START-like_dom.
DR   Pfam; PF10604; Polyketide_cyc2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Abscisic acid signaling pathway; Cell membrane;
KW   Complete proteome; Cytoplasm; Membrane; Nucleus;
KW   Protein phosphatase inhibitor; Receptor; Reference proteome.
FT   CHAIN         1    190       Abscisic acid receptor PYL2.
FT                                /FTId=PRO_0000391737.
FT   REGION       28    182       START-like.
FT   REGION       93     98       ABA binding.
FT                                {ECO:0000269|PubMed:19893533,
FT                                ECO:0000269|PubMed:19898420}.
FT   REGION      120    126       ABA binding.
FT                                {ECO:0000269|PubMed:19893533,
FT                                ECO:0000269|PubMed:19898420}.
FT   MOTIF        89     93       Gate loop. {ECO:0000269|PubMed:19898420}.
FT   MOTIF       119    121       Latch loop.
FT                                {ECO:0000269|PubMed:19898420}.
FT   BINDING      64     64       ABA. {ECO:0000269|PubMed:19893533,
FT                                ECO:0000269|PubMed:19898420}.
FT   BINDING     147    147       ABA. {ECO:0000269|PubMed:19893533,
FT                                ECO:0000269|PubMed:19898420}.
FT   SITE         92     92       Involved in interactions with PP2Cs.
FT                                {ECO:0000250|UniProtKB:O49686}.
FT   SITE        158    158       Involved in interactions with PP2Cs.
FT                                {ECO:0000250|UniProtKB:O49686}.
FT   SITE        166    166       Involved in ABA binding.
FT                                {ECO:0000250|UniProtKB:Q84MC7}.
FT   MUTAGEN      64     64       K->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19893533,
FT                                ECO:0000269|PubMed:19898420}.
FT   MUTAGEN      87     87       V->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN      87     87       V->L: Increased constitutive inhibition
FT                                of PP2C phosphatase.
FT                                {ECO:0000269|PubMed:21658606}.
FT   MUTAGEN      88     88       I->K: Monomer due to impaired
FT                                homodimerization. Increased ABA-binding
FT                                affinity and increased constitutive
FT                                inhibition of PP2C phosphatase.
FT                                {ECO:0000269|PubMed:21658606}.
FT   MUTAGEN      90     90       G->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN      91     91       L->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN      93     93       A->S: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN      98     98       E->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN     124    124       Y->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN     147    147       E->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN     151    151       V->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   MUTAGEN     173    173       N->A: Impaired ABA-mediated binding to
FT                                PP2Cs and subsequent inhibition.
FT                                {ECO:0000269|PubMed:19898420}.
FT   HELIX        12     25       {ECO:0000244|PDB:3KL1}.
FT   STRAND       34     45       {ECO:0000244|PDB:3KL1}.
FT   HELIX        47     55       {ECO:0000244|PDB:3KL1}.
FT   HELIX        60     62       {ECO:0000244|PDB:3KL1}.
FT   STRAND       65     78       {ECO:0000244|PDB:3KL1}.
FT   STRAND       82     87       {ECO:0000244|PDB:3KL1}.
FT   STRAND       89     92       {ECO:0000244|PDB:3KL1}.
FT   STRAND       94    104       {ECO:0000244|PDB:3KL1}.
FT   TURN        105    108       {ECO:0000244|PDB:3KL1}.
FT   STRAND      109    120       {ECO:0000244|PDB:3KL1}.
FT   STRAND      125    134       {ECO:0000244|PDB:3KL1}.
FT   TURN        136    138       {ECO:0000244|PDB:3NS2}.
FT   STRAND      141    152       {ECO:0000244|PDB:3KL1}.
FT   HELIX       159    183       {ECO:0000244|PDB:3KL1}.
SQ   SEQUENCE   190 AA;  21282 MW;  CBB16E64BE2B8164 CRC64;
     MSSSPAVKGL TDEEQKTLEP VIKTYHQFEP DPTTCTSLIT QRIHAPASVV WPLIRRFDNP
     ERYKHFVKRC RLISGDGDVG SVREVTVISG LPASTSTERL EFVDDDHRVL SFRVVGGEHR
     LKNYKSVTSV NEFLNQDSGK VYTVVLESYT VDIPEGNTEE DTKMFVDTVV KLNLQKLGVA
     ATSAPMHDDE
//
